Ketamine was originally approved by the FDA as an anesthetic, but is increasingly being used to treat mood disorders such as treatment-resistant depression, anxiety disorders, and PTSD.
Data from a multisite study of the effectiveness of cognitive behavioral therapy (CBT) support process-focused CBT as a means of reducing social anxiety.
Youth with OCD and hoarding symptoms do not have worse severity, impairment, or treatment outcome; however, they may have greater rates of diagnostic comorbidity.
Intolerance of uncertainty, depression, and obsessive-compulsive disorder symptoms during pregnancy were significant predictors of worsening postpartum anxiety.
RCADS is often used to measure anxiety and depression and researchers assessed its structural validity for adults, given the life span nature of anxiety.
A recent review found that existing psychosocial interventions using cognitive-behavioral and mindfulness-based approaches had a small but significant effect on quality of life and anxiety outcomes in patients with psoriasis.
Investigators conducted a comprehensive literature review to determine whether CBT is the most effective form of psychotherapy for children with anxiety disorders.
In patients with traumatic injury, there may be a benefit to starting paroxetine to prevent PTSD and associated symptoms, including numbing and avoidance.
